No material impact on GSK stock expected. Share Reward Plan acquisitions by PDMRs are routine compensation events, not discretionary insider buying. Monitor upcoming quarterly earnings for fundamental catalysts.
Price Chart
Executive Summary
This 6-K filing reports routine acquisitions of GSK ordinary shares by multiple PDMRs (senior executives) under the company's Share Reward Plan on September 9, 2026. Each PDMR acquired 14 shares (7 partnership + 7 matching) at £18.0296 per share. The transactions are plan-based and de minimis in size, representing no material signal for the stock.
Key Facts
- Nine PDMRs (including CFO Julie Brown, President Europe, President Corporate Development, CEO ViiV Healthcare) each acquired 14 ordinary shares under the Share Reward Plan
- All acquisitions executed on September 9, 2026 at £18.0296 per share on the London Stock Exchange
- Each PDMR received 7 partnership shares and 7 matching shares — standard plan structure
- Total shares acquired across all PDMRs: 126 shares (approximately £2,272 aggregate value)
- Transaction type is plan-based, not an open-market discretionary purchase
Financial Impact
De minimis – total consideration approximately £2,272 across all PDMRs at £18.0296/share
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-008280 |
| Document: 0001654954-26-008280-index-headers.html | 0001654954-26-008280 |
| Document: 0001654954-26-008280-index.html | 0001654954-26-008280 |
| Document: 0001654954-26-008280.txt | 0001654954-26-008280 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access